Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

Published Date: 25 Apr 2025

Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is largely due to a lack of effective therapy options. In a recent paper published in Nature, researchers ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

2.

Prostate cancer mortality is significantly reduced when docetaxel is used.

3.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

4.

Breast cancer: Why it's difficult to treat and what new approaches are on the horizon

5.

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot